DIPCOVAN:
Defense Institute of Physiology and Allied Sciences (DIPAS), a laboratory of Defence Research and Development Organisation (DRDO), has developed an antibody detection-based kit ‘DIPCOVAN’, the DIPAS-VDX COVID-19 IgG Antibody Microwell ELISA for sero-surveillance.
- The DIPCOVAN kit can detect both spike as well as nucleocapsid (S&N) proteins of the SARS-CoV-2 virus with a high sensitivity of 97 percent and specificity of 99 percent.
- The kit has been developed in association with Vanguard Diagnostics Pvt Ltd, a development and manufacturing diagnostics company based in New Delhi.
- DIPCOVAN is intended for the qualitative detection of IgG antibodies in human serum or plasma, targeting SARS-CoV-2 related antigens.
- It offers a significantly faster turn-around time as it requires just 75 minutes to conduct the test without any cross-reactivity with other diseases.
- The kit has a shelf life of 18 months.
